Robert P Skinner

US Patent:

6755768, Jun 29, 2004

Filed:

Dec 18, 2002

Appl. No.:

10/322949

Inventors:

Edgar Garcia-Rill - Little Rock AR
Robert D. Skinner - Little Rock AR
Nancy B. Reese - Conway AR

Assignee:

Board of Trustees of the University of Arkansas - Little Rock AR

International Classification:

A63B 2200

US Classification:

482 51, 482 7, 482 57, 482 60

Abstract:

A device for inducing a cycling motion in patients who have little or no motor control of their legs. The device has bicycle-type pedals connected via a belt or chain drive to a motor with a speed control allowing a very low rate of rotation from 0. 1 cycles per second up to about 1. 0 cycles per second. The device includes straps for wheelchair wheels for locking a wheelchair in position such that the patients feet may be strapped onto the pedals. The diameter of rotation of the pedals is adjustable to accommodate different leg lengths and to allow various diameters of rotation of the pedals. The motor is housed within a console with medial and lateral supports so that the legs of the patient are maintained in alignment.

US Patent:

7238370, Jul 3, 2007

Filed:

Oct 11, 2002

Appl. No.:

10/268801

Inventors:

E. William Rosenberg - Memphis TN, US
Robert B. Skinner - Memphis TN, US
George Flinn, Jr. - Memphis TN, US

International Classification:

A61K 9/14
A61K 9/00

US Classification:

424489, 424400

Abstract:

A method and composition for stimulating skin function to prevent and reverse the effects of photoaging, without removal of the protective stratum corneum. The composition of the invention is a mixture of coarse pumice and an aqueous surfactant emulsion.

US Patent:

20020031788, Mar 14, 2002

Filed:

Feb 20, 2001

Appl. No.:

09/789102

Inventors:

E. Rosenberg - Memphis TN, US
Patricia Noah - Germantown TN, US
Robert Skinner - Memphis TN, US
Timothy Mandrell - Memphis TN, US
Jagat Narula - Philadelphia PA, US
Charles Handorf - Memphis TN, US

International Classification:

G01N033/567
A61K049/00

US Classification:

435/007210, 424/009810

Abstract:

Methods for diagnosing a systemic or autoimmune disorder and methods for treating the same by inducing the production of or otherwise providing an autoantibody that recognizes a skin basement membrane component.

US Patent:

20070077206, Apr 5, 2007

Filed:

Oct 26, 2006

Appl. No.:

11/588192

Inventors:

E. Rosenberg - Memphis TN, US
Patricia Noah - Germantown TN, US
Robert Skinner - Memphis TN, US
Timothy Mandrell - Memphis TN, US
Jagat Narula - Philadelphia PA, US
Charles Handorf - Memphis TN, US

International Classification:

A61K 49/00

US Classification:

424009800

Abstract:

Methods for diagnosing a systemic or autoimmune disorder and methods for treating the same by inducing the production of or otherwise providing an autoantibody that recognizes a skin basement membrane component.

US Patent:

20080146674, Jun 19, 2008

Filed:

Dec 13, 2007

Appl. No.:

11/956054

Inventors:

E. William Rosenberg - Memphis TN, US
Robert B. Skinner - Memphis TN, US

International Classification:

A61K 31/13
A61P 17/00

US Classification:

514641

Abstract:

A composition and method for treating a skin problem, particularly atopic dermatitis, the composition comprising an antiseptic dye, preferably gentian violet, in a vehicle effective for topical administration.

US Patent:

20140004099, Jan 2, 2014

Filed:

Sep 4, 2013

Appl. No.:

14/017975

Inventors:

Robert Skinner - Little Rock AR, US
Evan Unger - Tucson AZ, US

International Classification:

A61K 31/02
A61K 38/48

US Classification:

424 9464, 514759

Abstract:

The present invention provides methods and combinations for reducing the infarct volume in a tissue of a subject undergoing ischemia or at risk of developing ischemia.

US Patent:

59901004, Nov 23, 1999

Filed:

Aug 28, 1998

Appl. No.:

9/143146

Inventors:

E. William Rosenberg - Memphis TN
Thomas M. Glenn - Mobile AL
Robert B. Skinner - Memphis TN
Patricia W. Noah - Germantown TN

Assignee:

Panda Pharmaceuticals, L.L.C. - Memphis TN
The University of Tennessee Research Corporation - Knoxville TN

International Classification:

A61K 31595

US Classification:

514174

Abstract:

Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.

US Patent:

59506350, Sep 14, 1999

Filed:

Jan 20, 1998

Appl. No.:

9/009515

Inventors:

Edgar Garcia-Rill - Roland AR
Robert D. Skinner - Little Rock AR
Harris Gellman - Little Rock AR

Assignee:

Board of Trustees of the University of Arkansas - Little Rock AR

International Classification:

A61B 1900
A61B 1734
A61M 2100

US Classification:

128898

Abstract:

A method of treating various anxiety-related disorders, such as Post-Traumatic Stress Disorder, panic attacks, or general anxiety disorder is disclosed. It has been found that the P1 midlatency auditory evoked potential of such patients undergoes increased amplitude and decreased habituation. Stimulation of three specific acupuncture points LR3, HT3, and PC6) on three different acupuncture meridians has been found to reduce the amplitude of the P1 potential using 20-minute periods of stimulation. Low frequency stimulation (around 5 Hz) was found to be most effective. Repeated periods of stimulation were also found to increase the effect of the treatment.